Saturday 17 October 2026
Export BDMD’s income statement to Excel — free account
Baird Medical Investment Holdings Limited
BDMD Healthcare Medical Devices
0.57
0.03
−5.00%
Follow BDMD
Target Price Range
Analyst price targets
Free accountTen years at a glance
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 9.67 | 9.75 | 10.19 | 1.05 | 1.02 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | 9.86 | 10.50 | 11.10 | 13.52 | 12.50 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | — | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | — | — | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | — | — | |||||
| EBT | — | — | — | — | — | (1) | 1 | — | — | — | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | — | — | — | |||||
| Net income | — | 0 | — | — | — | (1) | 1 | — | — | — | |||||
| Depreciation | — | — | — | — | — | — | — | — | — | — | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 | ||||
| Earnings | — | — | — | — | — | (0.02) | 0.02 | — | — | (0.98) | |||||
| Cash flow | — | — | — | — | — | (0.04) | (0.02) | — | — | 0.00 | |||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 | |||||
| Free cash flow | — | — | — | — | — | (0.04) | (0.02) | — | — | 0.00 | |||||
| Book value | — | — | — | — | — | 7.91 | 7.93 | — | — | 0.00 | |||||
| Shares, m | — | — | — | — | — | 29 | 29 | — | — | 28 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | — | — | — | — | — | |||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | |||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (1) | (1) | — | — | — | ||||
| Capex | — | — | — | — | — | — | — | — | — | — | |||||
| Free cash flow | — | — | — | — | — | (1) | (1) | — | — | — | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 0 | (2) | — | — | — | ||||
| Total debt | — | — | — | — | — | 0 | 0 | — | — | — | |||||
| Net debt | — | — | — | — | — | (1) | 0 | — | — | — | |||||
| Shareholders’ equity | — | — | — | — | — | 227 | 228 | — | — | — | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | (0.59) | 0.26 | — | — | (22.87) | ||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | — | — | — | |||||
| ROE | — | — | — | — | — | 0.00 | 0.27 | — | — | 0.00 | |||||
Negative figures in brackets.
Charts ten years each
Baird Medical Investment Holdings Limited vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| PMI Flag Ship Acquisition Corp | $23.4M | 0.5× | — (loss-making) | +38.62% (above 0%: growing) | n/m | +46.79% (above 0%: growing) | 20.85% | (156.70%) | Compare |
| NSPR InspireMD, Inc. | $22.3M | — (loss-making) | — (loss-making) | −0.39% (below 0%: shrinking) | n/m | −26.00% (below 0%: shrinking) | (43.70%) | (815.64%) | Compare |
| ARAY Accuray Incorporated | $20.8M | — (loss-making) | — (loss-making) | −20.87% (below 0%: shrinking) | n/m | +117.83% (above 0%: growing) | 35.22% | 5.47% | Compare |
| MODD Modular Medical, Inc. | $20.5M | — (loss-making) | — | — | n/m | −5.61% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| PAVM PAVmed Inc. | $19.4M | — (loss-making) | — (loss-making) | +450.00% (above 0%: growing) | n/m | −125.63% (below 0%: shrinking) | (269.70%) | (21,278.79%) | Compare |
| BDMD Baird Medical Investment Holdings Limited | $19.2M | — (loss-making) | — | — | n/m | −598.12% (below 0%: shrinking) | — | — | |
| LFWD Lifeward Ltd. | $17.2M | — (loss-making) | — (loss-making) | +15.71% (above 0%: growing) | n/m | −52.77% (below 0%: shrinking) | 40.90% | (62.69%) | Compare |
| ALUR Allurion Technologies, Inc. | $16.7M | — (loss-making) | — (loss-making) | −47.19% (below 0%: shrinking) | n/m | +65.98% (above 0%: growing) | 41.70% | (126.60%) | Compare |
| HSCS HeartSciences Inc. | $15.4M | — (loss-making) | — (loss-making) | −46.15% (below 0%: shrinking) | n/m | +18.18% (above 0%: growing) | 61.90% | (139,957.14%) | Compare |
| Median of peers | $20.0M | — | — | −0.39% | — | +6.28% | 28.04% | (141.65%) |
Baird Medical Investment Holdings Limited (BDMD) key facts
- Baird Medical Investment Holdings Limited (BDMD) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- Net income was $623,100.00, or −$0.98 per share (basic), a net margin of 0.00%.
- As of October 16, 2026, BDMD traded at $0.57, a market capitalization of $19.2 million.
- Return on equity was 0.00% and debt-to-equity 0.03.
Baird Medical Investment Holdings Limited (BDMD) Latest News
No news at this impact. Lower the threshold for more.